Drugs for Myelofibrosis/Polycythemia Vera

Table. Drugs Prescribed for Myelofibrosis or Polycythemia Vera

• Drug name (generic name)
• Drug company
• Indications
• Patient support services

Drug name (generic name)
• Inrebic (fedratinib) Capsules
Drug company
• Bristol Myers Squibb
Indication
• Treatment of adults with intermediate-2 or highrisk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis
Patient support services
• BMS Oncology Co‑Pay Assistance Program
  800-861-0048
  
  Bristol Myers Squibb Patient Assistance Foundation
  800-736-0003

Drug name (generic name)
• Jakafi (ruxolitinib) Tablets
Drug company
• Incyte
Indication
• Treatment of intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis, and post-essential thrombocythemia myelofibrosis
  
  Treatment of polycythemia vera in patients who cannot use or have an inadequate response to hydroxyurea
Patient support services
• IncyteCARES for Jakafi Savings Program
  855-452-5234
  
  IncyteCARES for Jakafi Patient Assistance Program
  855-452-5234
  
  IncyteCARES for Jakafi Temporary Access Program
  855-452-5234

Drug name (generic name)
• Vonjo (pacritinib) Capsules
Drug company
• CTI BioPharma
Indication
• Treatment of adults with intermediate- or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis with a platelet count below 50 × 10⁹/L
Patient support services
• CTI Access Co‑pay Assistance
  888-284-3678
  
  Patient Assistance Program
  888-284-3678
  
  Bridge Program
  888-284-3678